Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Signos vs Found

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Signos logo

Signos

7.5
★★★3.8/5

Best for: Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app

Visit Signos
VS
Found logo

Found

8.3
★★★★4.2/5

Best for: mainstream telehealth GLP-1 access

Visit Found

Signos and Found are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Found starts lower at $149/mo versus $199/mo, and Found edges ahead overall (8.3 vs 7.5 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Signos

6-month programCompounded
$199/mo
semaglutide
StartingCompounded
$199/mo
tirzepatide

Signos+ GLP-1 bundle (tirzepatide OR semaglutide) from $199/mo; includes CGM system

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 390+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Signos

What the monthly price covers

Medication

Included

Provider visits

Not disclosed

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Found

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Signos

7.5/10

Overall

Found

8.3/10

Value25%

7.5A
vs
B
8.5

Effectiveness25%

7.5A
vs
B
9.0

User Experience15%

7.5A
vs
B
8.0

Trust & Safety15%

7.8A
vs
B
7.3

Accessibility10%

7.0A
vs
B
8.5

Support10%

7.5A
vs
B
7.5

Features & Coverage

FeatureSignosFound
Starting Price$199/mo$149/mo
Features8 features3 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted✓ Yes
FDA WarningsNoneNone

About Signos

Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with real-time glucose data and coaching so users understand and sustain their weight loss. The program starts at $199/mo on a 6-month plan, includes free shipping, and is HSA/FSA eligible. It is pitched as the same price as medication alone, with the CGM added.

Read our full Signos review →

About Found

Personalized weight care platform with a self-pay membership model plus medication costs.

Read our full Found review →

Pros & Cons

Signos

What we like

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Watch-outs

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

Found

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Our Verdict

Winner: Found

Found edges out Signos with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. Signos remains a solid alternative, especially if you're looking for Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.

Choose Signos if…

You want Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app and a starting price around $199/mo.

Choose Found if…

You want mainstream telehealth GLP-1 access and a starting price around $149/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.0

ShedRx

Mainstream telehealth GLP-1 access

8.1

bmiMD

Mainstream telehealth GLP-1 access

7.7

Synergy Rx

Broadest drug catalog in the Lion MD white-label cluster

Signos vs Found: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Signos and Found head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.